Pfg Advisors Biogen Inc. Transaction History

Pfg Advisors

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 19, 2024	BUY	$222.59 - $267.94 $20,255 - $24,382	91 Added 9.24%	1,076 $278,000
Q3 2023 Oct 13, 2023	BUY	$253.3 - $285.89 $14,691 - $16,581	58 Added 6.26%	985 $253,000
Q2 2023 Jul 20, 2023	BUY	$275.25 - $318.06 $8,808 - $10,177	32 Added 3.58%	927 $264,000
Q1 2023 Apr 20, 2023	BUY	$256.56 - $292.34 $229,621 - $261,644	895 New	895 $248,000
Q3 2021 Nov 05, 2021	SELL	$282.99 - $369.05 $178,566 - $232,870	-631 Closed	0 $0
Q2 2021 Jul 28, 2021	SELL	$259.0 - $414.71 $33,411 - $53,497	-129 Reduced 16.97%	631 $218,000
Q1 2021 Apr 27, 2021	BUY	$242.95 - $284.63 $184,642 - $216,318	760 New	760 $213,000
Q4 2020 Jan 26, 2021	SELL	$236.26 - $355.63 $203,183 - $305,841	-860 Closed	0 $0
Q3 2020 Oct 13, 2020	SELL	$264.77 - $305.71 $11,914 - $13,756	-45 Reduced 4.97%	860 $246,000
Q2 2020 Jul 16, 2020	SELL	$258.66 - $342.55 $6,466 - $8,563	-25 Reduced 2.69%	905 $252,000
Q1 2020 Apr 29, 2020	SELL	$268.85 - $341.04 $537 - $682	-2 Reduced 0.21%	930 $316,000
Q3 2019 Oct 15, 2019	SELL	$217.44 - $243.88 $70,885 - $79,504	-326 Reduced 25.91%	932 $207,000
Q2 2019 Aug 05, 2019	SELL	$219.29 - $241.72 $41,665 - $45,926	-190 Reduced 13.12%	1,258 $300,000
Q1 2019 May 08, 2019	BUY	$216.71 - $338.96 $24,921 - $38,980	115 Added 8.63%	1,448 $332,000
Q4 2018 Feb 19, 2019	SELL	$278.5 - $352.75 $69,346 - $87,834	-249 Reduced 15.74%	1,333 $426,000
Q4 2018 Jan 18, 2019	BUY	$278.5 - $352.75 $440,587 - $558,050	1,582 New	1,582 $517,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Pfg Advisors, based on Form 13F filings with the SEC.

Stay updated on Pfg Advisors with notifications on news.